Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_assertion type Assertion NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_head.
- NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_assertion description "[Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_provenance.
- NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_assertion evidence source_evidence_literature NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_provenance.
- NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_assertion SIO_000772 25650377 NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_provenance.
- NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_assertion wasDerivedFrom befree-2016 NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_provenance.
- NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_assertion wasGeneratedBy ECO_0000203 NP1260897.RAXfzua69etgchHE3I_1p70JypVE6veYuC4GjH4YbnnC8130_provenance.